Maxigesic approval positive for AFT Pharmaceuticals
Trainee reporter
funded through
Unlock all stories free for 10 days
Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
We won’t charge for 10 days. You can cancel anytime with two clicks, an email or a phone call. Find out more.
We are serious about journalism.
You will be charged in 10 days unless you cancel beforehand.
We will remind you three times before charging you.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Or use the information you’ve already given Google to create your subscription.
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
NZ sharemarket falls due to global inflation fears
The S&P/NZX 50 Index closed at 11,867.58, down 89.92 points or 0.75%.
Weaker than expected jobs data won't move the rate cut dial
The March quarter jobs data was gloomier than expected.
WBD's Glen Kyne steps down
Warner Bros Discovery NZ boss Glen Kyne will leave the company in July.
Cyber alerts in New Zealand on the rise
A shortage of security experts puts pressure on combating threats
Avoiding mistakes many investors make
Managing emotions key to securing long-term returns.
